| Variables . | Total redo CABG . | On-pump redo CABG . | Redo OPCAB . | P-value . |
|---|---|---|---|---|
| Patients | 617 | 253 | 364 | |
| Sex (male) | 78.8 | 79.8 | 78.0 | 0.62 |
| Age (years), mean (SD) | 69.35 ± 9.2 | 68.87 ± 9.74 | 69.68 ± 8.81 | 0.28 |
| Body surface area, mean (SD) | 1.64 ± 0.18 | 1.64 ± 0.18 | 1.64 ± 0.18 | 0.54 |
| Smoking | 52.4 | 49.8 | 54.1 | 0.33 |
| Body mass index >30 kg/m2 | 5.2 | 5.1 | 5.2 | 1.00 |
| Diabetes | 46.2 | 45.5 | 46.7 | 0.81 |
| Preoperative creatinine value | 1.73 ± 2.29 | 1.68 ± 2.29 | 1.76 ± 2.29 | 0.70 |
| Renal failure | 18.5 | 18.2 | 18.7 | 0.92 |
| Dialysis | 9.1 | 9.6 | 9.4 | 0.89 |
| Hyperlipidaemia | 60.8 | 59.3 | 61.8 | 0.56 |
| Hypertension | 77.6 | 80.2 | 75.8 | 0.20 |
| Cerebrovascular disease | 11.0 | 12.6 | 9.9 | 0.30 |
| Carotid stenosis | 7.9 | 7.9 | 8.0 | 1.00 |
| COPD (moderate and severe) | 11.3 | 10.3 | 12.1 | 0.52 |
| Extracardiac disease | 20.9 | 23.7 | 19.0 | 0.16 |
| Peripheral | 18.0 | 19.8 | 16.8 | 0.34 |
| Myocardial infarction | 44.9 | 46.6 | 43.7 | 0.51 |
| Previous coronary artery intervention | 45.4 | 44.7 | 45.9 | 0.81 |
| Unstable angina | 32.9 | 38.3 | 29.1 | 0.019 |
| Shock | 4.9 | 7.9 | 2.7 | 0.0040 |
| Congestive heart failure | 14.7 | 17.0 | 13.2 | 0.21 |
| Arrhythmia | 11.7 | 13.8 | 10.2 | 0.16 |
| NYHA class III or IV | 28.4 | 31.2 | 26.4 | 0.20 |
| Diseased vessels, % | ||||
| Left main disease | 37.0 | 42.7 | 33.0 | 0.017 |
| 1 | 13.9 | 9.9 | 16.8 | 0.018 |
| 2 | 25.0 | 20.2 | 28.3 | 0.023 |
| Triple-vessel disease | 55.3 | 62.1 | 50.5 | 0.0050 |
| LV impairment, % | ||||
| Good >EF:60% | 34.5 | 35.2 | 34.1 | 0.80 |
| ≤EF:60% | 65.2 | 64.0 | 65.9 | 0.67 |
| Bad <EF:30% | 8.1 | 9.9 | 6.9 | 0.18 |
| Mitral valve insufficiency II–IV | 21.1 | 20.9 | 21.2 | 1.00 |
| Tricuspid valve insufficiency II–IV | 14.6 | 17.4 | 12.6 | 0.11 |
| Status, % | ||||
| Urgent | 8.3 | 9.9 | 7.1 | 0.24 |
| Emergency/salvage | 8.1 | 10.7 | 6.3 | 0.071 |
| Japan SCORE | ||||
| Expected 30 days operative mortality | 7.66 ± 0.14 | 5.51 ± 0.1 | 0.023 | |
| Expected composite 30-day mortality or major morbidity | 25.1 ± 0.18 | 21.9 ± 0.15 | 0.019 | |
| Variables . | Total redo CABG . | On-pump redo CABG . | Redo OPCAB . | P-value . |
|---|---|---|---|---|
| Patients | 617 | 253 | 364 | |
| Sex (male) | 78.8 | 79.8 | 78.0 | 0.62 |
| Age (years), mean (SD) | 69.35 ± 9.2 | 68.87 ± 9.74 | 69.68 ± 8.81 | 0.28 |
| Body surface area, mean (SD) | 1.64 ± 0.18 | 1.64 ± 0.18 | 1.64 ± 0.18 | 0.54 |
| Smoking | 52.4 | 49.8 | 54.1 | 0.33 |
| Body mass index >30 kg/m2 | 5.2 | 5.1 | 5.2 | 1.00 |
| Diabetes | 46.2 | 45.5 | 46.7 | 0.81 |
| Preoperative creatinine value | 1.73 ± 2.29 | 1.68 ± 2.29 | 1.76 ± 2.29 | 0.70 |
| Renal failure | 18.5 | 18.2 | 18.7 | 0.92 |
| Dialysis | 9.1 | 9.6 | 9.4 | 0.89 |
| Hyperlipidaemia | 60.8 | 59.3 | 61.8 | 0.56 |
| Hypertension | 77.6 | 80.2 | 75.8 | 0.20 |
| Cerebrovascular disease | 11.0 | 12.6 | 9.9 | 0.30 |
| Carotid stenosis | 7.9 | 7.9 | 8.0 | 1.00 |
| COPD (moderate and severe) | 11.3 | 10.3 | 12.1 | 0.52 |
| Extracardiac disease | 20.9 | 23.7 | 19.0 | 0.16 |
| Peripheral | 18.0 | 19.8 | 16.8 | 0.34 |
| Myocardial infarction | 44.9 | 46.6 | 43.7 | 0.51 |
| Previous coronary artery intervention | 45.4 | 44.7 | 45.9 | 0.81 |
| Unstable angina | 32.9 | 38.3 | 29.1 | 0.019 |
| Shock | 4.9 | 7.9 | 2.7 | 0.0040 |
| Congestive heart failure | 14.7 | 17.0 | 13.2 | 0.21 |
| Arrhythmia | 11.7 | 13.8 | 10.2 | 0.16 |
| NYHA class III or IV | 28.4 | 31.2 | 26.4 | 0.20 |
| Diseased vessels, % | ||||
| Left main disease | 37.0 | 42.7 | 33.0 | 0.017 |
| 1 | 13.9 | 9.9 | 16.8 | 0.018 |
| 2 | 25.0 | 20.2 | 28.3 | 0.023 |
| Triple-vessel disease | 55.3 | 62.1 | 50.5 | 0.0050 |
| LV impairment, % | ||||
| Good >EF:60% | 34.5 | 35.2 | 34.1 | 0.80 |
| ≤EF:60% | 65.2 | 64.0 | 65.9 | 0.67 |
| Bad <EF:30% | 8.1 | 9.9 | 6.9 | 0.18 |
| Mitral valve insufficiency II–IV | 21.1 | 20.9 | 21.2 | 1.00 |
| Tricuspid valve insufficiency II–IV | 14.6 | 17.4 | 12.6 | 0.11 |
| Status, % | ||||
| Urgent | 8.3 | 9.9 | 7.1 | 0.24 |
| Emergency/salvage | 8.1 | 10.7 | 6.3 | 0.071 |
| Japan SCORE | ||||
| Expected 30 days operative mortality | 7.66 ± 0.14 | 5.51 ± 0.1 | 0.023 | |
| Expected composite 30-day mortality or major morbidity | 25.1 ± 0.18 | 21.9 ± 0.15 | 0.019 | |
Values are percentage or mean ± SD values.
COPD: chronic obstructive pulmonary disease; NYHA: New York Heart Association; LV: left ventricular; EF: ejection fraction.
| Variables . | Total redo CABG . | On-pump redo CABG . | Redo OPCAB . | P-value . |
|---|---|---|---|---|
| Patients | 617 | 253 | 364 | |
| Sex (male) | 78.8 | 79.8 | 78.0 | 0.62 |
| Age (years), mean (SD) | 69.35 ± 9.2 | 68.87 ± 9.74 | 69.68 ± 8.81 | 0.28 |
| Body surface area, mean (SD) | 1.64 ± 0.18 | 1.64 ± 0.18 | 1.64 ± 0.18 | 0.54 |
| Smoking | 52.4 | 49.8 | 54.1 | 0.33 |
| Body mass index >30 kg/m2 | 5.2 | 5.1 | 5.2 | 1.00 |
| Diabetes | 46.2 | 45.5 | 46.7 | 0.81 |
| Preoperative creatinine value | 1.73 ± 2.29 | 1.68 ± 2.29 | 1.76 ± 2.29 | 0.70 |
| Renal failure | 18.5 | 18.2 | 18.7 | 0.92 |
| Dialysis | 9.1 | 9.6 | 9.4 | 0.89 |
| Hyperlipidaemia | 60.8 | 59.3 | 61.8 | 0.56 |
| Hypertension | 77.6 | 80.2 | 75.8 | 0.20 |
| Cerebrovascular disease | 11.0 | 12.6 | 9.9 | 0.30 |
| Carotid stenosis | 7.9 | 7.9 | 8.0 | 1.00 |
| COPD (moderate and severe) | 11.3 | 10.3 | 12.1 | 0.52 |
| Extracardiac disease | 20.9 | 23.7 | 19.0 | 0.16 |
| Peripheral | 18.0 | 19.8 | 16.8 | 0.34 |
| Myocardial infarction | 44.9 | 46.6 | 43.7 | 0.51 |
| Previous coronary artery intervention | 45.4 | 44.7 | 45.9 | 0.81 |
| Unstable angina | 32.9 | 38.3 | 29.1 | 0.019 |
| Shock | 4.9 | 7.9 | 2.7 | 0.0040 |
| Congestive heart failure | 14.7 | 17.0 | 13.2 | 0.21 |
| Arrhythmia | 11.7 | 13.8 | 10.2 | 0.16 |
| NYHA class III or IV | 28.4 | 31.2 | 26.4 | 0.20 |
| Diseased vessels, % | ||||
| Left main disease | 37.0 | 42.7 | 33.0 | 0.017 |
| 1 | 13.9 | 9.9 | 16.8 | 0.018 |
| 2 | 25.0 | 20.2 | 28.3 | 0.023 |
| Triple-vessel disease | 55.3 | 62.1 | 50.5 | 0.0050 |
| LV impairment, % | ||||
| Good >EF:60% | 34.5 | 35.2 | 34.1 | 0.80 |
| ≤EF:60% | 65.2 | 64.0 | 65.9 | 0.67 |
| Bad <EF:30% | 8.1 | 9.9 | 6.9 | 0.18 |
| Mitral valve insufficiency II–IV | 21.1 | 20.9 | 21.2 | 1.00 |
| Tricuspid valve insufficiency II–IV | 14.6 | 17.4 | 12.6 | 0.11 |
| Status, % | ||||
| Urgent | 8.3 | 9.9 | 7.1 | 0.24 |
| Emergency/salvage | 8.1 | 10.7 | 6.3 | 0.071 |
| Japan SCORE | ||||
| Expected 30 days operative mortality | 7.66 ± 0.14 | 5.51 ± 0.1 | 0.023 | |
| Expected composite 30-day mortality or major morbidity | 25.1 ± 0.18 | 21.9 ± 0.15 | 0.019 | |
| Variables . | Total redo CABG . | On-pump redo CABG . | Redo OPCAB . | P-value . |
|---|---|---|---|---|
| Patients | 617 | 253 | 364 | |
| Sex (male) | 78.8 | 79.8 | 78.0 | 0.62 |
| Age (years), mean (SD) | 69.35 ± 9.2 | 68.87 ± 9.74 | 69.68 ± 8.81 | 0.28 |
| Body surface area, mean (SD) | 1.64 ± 0.18 | 1.64 ± 0.18 | 1.64 ± 0.18 | 0.54 |
| Smoking | 52.4 | 49.8 | 54.1 | 0.33 |
| Body mass index >30 kg/m2 | 5.2 | 5.1 | 5.2 | 1.00 |
| Diabetes | 46.2 | 45.5 | 46.7 | 0.81 |
| Preoperative creatinine value | 1.73 ± 2.29 | 1.68 ± 2.29 | 1.76 ± 2.29 | 0.70 |
| Renal failure | 18.5 | 18.2 | 18.7 | 0.92 |
| Dialysis | 9.1 | 9.6 | 9.4 | 0.89 |
| Hyperlipidaemia | 60.8 | 59.3 | 61.8 | 0.56 |
| Hypertension | 77.6 | 80.2 | 75.8 | 0.20 |
| Cerebrovascular disease | 11.0 | 12.6 | 9.9 | 0.30 |
| Carotid stenosis | 7.9 | 7.9 | 8.0 | 1.00 |
| COPD (moderate and severe) | 11.3 | 10.3 | 12.1 | 0.52 |
| Extracardiac disease | 20.9 | 23.7 | 19.0 | 0.16 |
| Peripheral | 18.0 | 19.8 | 16.8 | 0.34 |
| Myocardial infarction | 44.9 | 46.6 | 43.7 | 0.51 |
| Previous coronary artery intervention | 45.4 | 44.7 | 45.9 | 0.81 |
| Unstable angina | 32.9 | 38.3 | 29.1 | 0.019 |
| Shock | 4.9 | 7.9 | 2.7 | 0.0040 |
| Congestive heart failure | 14.7 | 17.0 | 13.2 | 0.21 |
| Arrhythmia | 11.7 | 13.8 | 10.2 | 0.16 |
| NYHA class III or IV | 28.4 | 31.2 | 26.4 | 0.20 |
| Diseased vessels, % | ||||
| Left main disease | 37.0 | 42.7 | 33.0 | 0.017 |
| 1 | 13.9 | 9.9 | 16.8 | 0.018 |
| 2 | 25.0 | 20.2 | 28.3 | 0.023 |
| Triple-vessel disease | 55.3 | 62.1 | 50.5 | 0.0050 |
| LV impairment, % | ||||
| Good >EF:60% | 34.5 | 35.2 | 34.1 | 0.80 |
| ≤EF:60% | 65.2 | 64.0 | 65.9 | 0.67 |
| Bad <EF:30% | 8.1 | 9.9 | 6.9 | 0.18 |
| Mitral valve insufficiency II–IV | 21.1 | 20.9 | 21.2 | 1.00 |
| Tricuspid valve insufficiency II–IV | 14.6 | 17.4 | 12.6 | 0.11 |
| Status, % | ||||
| Urgent | 8.3 | 9.9 | 7.1 | 0.24 |
| Emergency/salvage | 8.1 | 10.7 | 6.3 | 0.071 |
| Japan SCORE | ||||
| Expected 30 days operative mortality | 7.66 ± 0.14 | 5.51 ± 0.1 | 0.023 | |
| Expected composite 30-day mortality or major morbidity | 25.1 ± 0.18 | 21.9 ± 0.15 | 0.019 | |
Values are percentage or mean ± SD values.
COPD: chronic obstructive pulmonary disease; NYHA: New York Heart Association; LV: left ventricular; EF: ejection fraction.
This PDF is available to Subscribers Only
View Article Abstract & Purchase OptionsFor full access to this pdf, sign in to an existing account, or purchase an annual subscription.
